Back to
STATE STREET CORP
CORT
Showing 8 of 28 quarters
Position history for
STATE STREET CORP's holdings in Corcept Therapeutics Incorporated.
Yes. State Street holds 3,279,381 shares of CORT (Corcept Therapeutics), worth $285.2M, as of its Q2 2026 13F filing. It increased the position by 78,435 shares (+2.5%) from Q1 2026. State Street has held CORT in every 13F on record since Q3 2019, 28 quarterly filings.
Current Value
$285.2M
Current Shares
3.3M
Total Value Change
+$122.3M
Total Shares Change
-239,882
Quarter-by-Quarter History